Honasa Buys 58% Of Fluence Pharma, Pushes Mamaearth Into Beauty-From-Within
Mamaearth parent Honasa Consumer has acquired a 58% stake in Fluence Pharma, launching a new subsidiary Honasa Health under Dheeraj Nagpal to enter India's Rs 16,000 crore beauty-from-within nutraceuticals category alongside its existing Zingavita play.
Honasa Consumer, parent of Mamaearth, acquired a 58% stake in nutraceuticals firm Fluence Pharma to enter India's Rs 16,000 crore beauty-from-within segment via a new subsidiary, Honasa Health, led by Dheeraj Nagpal.
Why this matters
Honasa is diversifying its Mamaearth-led portfolio into ingestibles, layering Fluence Pharma onto its existing Zingavita nutraceuticals bet to capture beauty-from-within demand.
Retail-company signals steady at 3,576 in last 90 days.